1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. California >
  6. Centauri Therapeutics Acquires Alphamer Technology

M&A Deal Summary

Centauri Therapeutics Acquires Alphamer Technology

On January 18, 2016, Centauri Therapeutics acquired life science company Alphamer Technology from Altermune Technologies

Acquisition Highlights
  • This is Centauri Therapeutics’ 1st transaction in the Life Science sector.
  • This is Centauri Therapeutics’ 1st transaction in the United States.
  • This is Centauri Therapeutics’ 1st transaction in California.

M&A Deal Summary
Date 2016-01-18
Target Alphamer Technology
Sector Life Science
Buyer(s) Centauri Therapeutics
Sellers(s) Altermune Technologies
Deal Type Divestiture

Target

Alphamer Technology

Irvine, California, United States
Alphamer Technology is a provider of immuno therapeutics platform technology.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Centauri Therapeutics

London, United Kingdom
Category Company
Sector Life Science
DESCRIPTION

Centauri Therapeutics Ltd. is a biotechnology company focused on the discovery and development of novel molecules targeting life threatening diseases.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1

Seller(S) 1

SELLER

Altermune Technologies

Irvine, California, United States
Category Company
Founded 2010
Sector Life Science
DESCRIPTION

Altermune Technologies LLC is a provider of adaptable immunotherapy platform with a novel mechanism of action against cancer & infectious disease.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2016 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal